首页> 外文期刊>Diabetes >Haptoglobin 1-1 Genotype Modulates the Association of Glycemic Control With Hippocampal Volume in Elderly Individuals With Type 2 Diabetes
【24h】

Haptoglobin 1-1 Genotype Modulates the Association of Glycemic Control With Hippocampal Volume in Elderly Individuals With Type 2 Diabetes

机译:Haptoglobin 1-1基因型可调节2型糖尿病老年患者血糖控制与海马体积的相关性

获取原文
获取原文并翻译 | 示例
       

摘要

Recent evidence suggests that glycemic control is associated with cognitive function in older patients with type 2 diabetes who are carriers of the haptoglobin (Hp) 1-1 genotype compared with noncarriers. We assessed whether poor glycemic control in Hp 1-1 carriers is more strongly associated with smaller hippocampal volume than in non-carriers. Hippocampal volume was generated from high-resolution structural T1 MRI obtained for 224 participants (28 Hp 1-1 carriers [12.5%] and 196 noncarriers [87.5%]) from the Israel Diabetes and Cognitive Decline (IDCD) study, who had a mean (SD) number of years in the Maccabi Healthcare Services (MHS) registry of 8.35 (2.63) and a mean (SD) HbA_(1c) level of 6.66 (0.73)% [49 mmol/mol]. A stronger negative association between right hippocampal volume and HbA_(1c) was found in patients with the Hp 1-1 genotype, with a 0.032-mL decrease in right hippocampal volume per 14% increase in HbA_(1c) (P = 0.0007) versus a 0.009-mL decrease in Hp 1 -1 noncarriers (P = 0.047), after adjusting for total intracranial volume, age, sex, follow-up years in the registry, and cardiovascular factor (interaction, P = 0.025). This indicates that 29.66% of the total variance in right hippocampal volume is explained by HbA_(1c) levels among Hp 1-1 carriers and that 3.22% is explained by HbA_(1c) levels among Hp 1-1 noncarriers. Our results suggest that the hippocampus of Hp 1-1 carriers may be more vulnerable to the insults of poor glycemic control.
机译:最新证据表明,与非携带者相比,携带触珠蛋白(Hp)1-1基因型的老年2型糖尿病患者的血糖控制与认知功能有关。我们评估了Hp 1-1携带者的血糖控制不佳是否与非携带者的海马体积更紧密相关。从以色列糖尿病和认知下降(IDCD)研究的224位参与者(28 Hp 1-1携带者[12.5%]和​​196位非携带者[IDCD])获得的高分辨率结构性T1 MRI中产生海马体积Maccabi Healthcare Services(MHS)注册表中的(SD)年数为8.35(2.63),HbA_(1c)平均(SD)水平为6.66(0.73)%[49 mmol / mol]。 Hp 1-1基因型患者的右海马体积与HbA_(1c)之间的负相关性更强,每增加14%HbA_(1c)右海马体积减少0.032-mL(P = 0.0007)在校正总颅内体积,年龄,性别,登记中的随访年数和心血管因素(相互作用,P = 0.025)后,Hp 1 -1非携带者的0.009-mL降低(P = 0.047)。这表明,在Hp 1-1携带者中,右海马体积总变异的29.66%由HbA_(1c)水平解释,而在Hp 1-1非携带者中,由HbA_(1c)水平解释了3.22%。我们的结果表明,Hp 1-1携带者的海马区可能更容易受到血糖控制不良的伤害。

著录项

  • 来源
    《Diabetes》 |2017年第11期|2927-2932|共6页
  • 作者单位

    Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Israel,The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel;

    The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel,Memory Clinic, Sheba Medical Center, Tel HaShomer, Israel,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;

    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel,Maccabi Healthcare Services, Tel Aviv, Israel;

    Maccabi Healthcare Services, Tel Aviv, Israel;

    Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Israel,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;

    Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Israel,Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;

    Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Israel;

    Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Israel;

    Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Israel;

    lcahn School of Medicine at Mount Sinai, New York, NY;

    The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel,lnterdisciplinary Center Herzliya, Baruch Ivcher School of Psychology, Herzliya, Israel;

    The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel,The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel HaShomer, Israel;

    lcahn School of Medicine at Mount Sinai, New York, NY,James J. Peters VA Medical Center, Bronx, NY;

    The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel;

    lcahn School of Medicine at Mount Sinai, New York, NY;

    Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Israel,Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Israel;

    Department of Diagnostic Imaging, Sheba Medical Center, Tel HaShomer, Israel,The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel;

    The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel HaShomer, Israel,lcahn School of Medicine at Mount Sinai, New York, NY,lnterdisciplinary Center Herzliya, Baruch Ivcher School of Psychology, Herzliya, Israel;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:03

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号